<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hayashida A</submitter><funding>NEI NIH HHS</funding><pagination>e9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11218895</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1(3)</volume><pubmed_abstract>A large number of bacterial pathogens bind to host extracellular matrix (ECM) components. For example, many Gram-negative and Gram-positive pathogens express binding proteins for fibronectin (FN) on their cell surface. Mutagenesis studies of bacterial FN-binding proteins have demonstrated their importance in pathogenesis in preclinical animal models. However, means to draw on these findings to design therapeutic approaches that specifically target FN-bacteria interactions have not been successful because bacterial pathogens can elaborate several FN-binding proteins and also because FN is an essential protein and likely a nondruggable target. Here we report that select heparan compounds potently inhibit &lt;i>Streptococcus pneumoniae&lt;/i> infection of injured corneas in mice. Using intact hepar</pubmed_abstract><journal>Proteoglycan research</journal><pubmed_title>Sulfated motifs in heparan sulfate inhibit &lt;i>Streptococcus pneumoniae&lt;/i> adhesion onto fibronectin and attenuate corneal infection.</pubmed_title><pmcid>PMC11218895</pmcid><funding_grant_id>R01 EY021765</funding_grant_id><funding_grant_id>R01 EY033025</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Saeed HN</pubmed_authors><pubmed_authors>Parks WC</pubmed_authors><pubmed_authors>Bispo PJM</pubmed_authors><pubmed_authors>Hayashida A</pubmed_authors><pubmed_authors>Park PW</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sulfated motifs in heparan sulfate inhibit &lt;i>Streptococcus pneumoniae&lt;/i> adhesion onto fibronectin and attenuate corneal infection.</name><description>A large number of bacterial pathogens bind to host extracellular matrix (ECM) components. For example, many Gram-negative and Gram-positive pathogens express binding proteins for fibronectin (FN) on their cell surface. Mutagenesis studies of bacterial FN-binding proteins have demonstrated their importance in pathogenesis in preclinical animal models. However, means to draw on these findings to design therapeutic approaches that specifically target FN-bacteria interactions have not been successful because bacterial pathogens can elaborate several FN-binding proteins and also because FN is an essential protein and likely a nondruggable target. Here we report that select heparan compounds potently inhibit &lt;i>Streptococcus pneumoniae&lt;/i> infection of injured corneas in mice. Using intact hepar</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2025-04-04T23:54:14.714Z</modification><creation>2025-04-04T23:54:14.714Z</creation></dates><accession>S-EPMC11218895</accession><cross_references><pubmed>38957622</pubmed><doi>10.1002/pgr2.9</doi></cross_references></HashMap>